Company intelligence / Profile preview

ASTA Pharmaceutical

Ownership: Private
Development stage: Preclinical

Overview

Asta Pharmaceuticals focused on research and development of natural astaxanthin for prevention and treatment of chronic diseases. The company is now closed, with no recent clinical results available[4].

Therapeutic areas: Chronic Diseases
Modalities: Small molecule
Industry: Biotech

Drug pipeline

1 asset

astaxanthin derivative

Pre-clinical

Indications: Inflammation

Partnerships

None reported in public sources.

Beyond the preview

Go deeper on ASTA Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ASTA Pharmaceutical.

Explore the full profile